Stock Market News2 months J&J’s Ketamine-Derived Drug Is Taking Off The Wall Street Journal
Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path forward for psychedelic-based medicines.
X1 day Johnson & Johnson (JNJ) Ascends But Remains Behind Market: Some Facts to Note Zacks
X6 days Johnson & Johnson: Dividend Legend At A Discount Seeking Alpha
X1 week FDA Gives CRL to J&J’s BLA for Subcutaneous Rybrevant in NSCLC Zacks
X1 week Johnson & Johnson (JNJ) Stock Declines While Market Improves: Some Information for Investors Zacks
X2 weeks J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports Investing.com
X2 weeks Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X2 weeks Johnson & Johnson (JNJ) Stock Moves -0.25%: What You Should Know Zacks
X2 weeks Johnson & Johnson Just Paid Investors: Here’s How Much They Received 24/7 Wall St.
X3 weeks Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Seeking Alpha
X3 weeks Pharma Stock Roundup: LLY’s Zepbound Success, FDA Updates for MRK, JNJ Zacks
X3 weeks The Zacks Analyst Blog Highlights Home Depot, Johnson & Johnson, Salesforce, Preformed Line and Cooper-Standard Zacks
X3 weeks Top Analyst Reports for Home Depot, Johnson & Johnson & Salesforce Zacks
X3 weeks Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks
X3 weeks J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids Zacks
X3 weeks J&J baby powder lawsuits stay paused amid bankruptcy trial plans Investing.com
X3 weeks Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know Zacks
X4 weeks How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding Seeking Alpha
X4 weeks J&J Seeks FDA Nod for Subcutaneous Tremfya as Induction Regimen in UC Zacks
X1 month J&J Loses Around $24B in a Month: How to Play the Stock? Zacks
X1 month Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive Seeking Alpha
X1 month Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks
X1 month Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript) Seeking Alpha
X1 month CHMP Endorses J&J’s Rybrevant-Lazcluze Combo for Use in NSCLC Zacks
X1 month Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program Yahoo Finance
X1 month Why Is Johnson & Johnson (JNJ) Down 6.7% Since Last Earnings Report? Zacks
X1 month Compared to Estimates, J&J Snack Foods (JJSF) Q4 Earnings: A Look at Key Metrics Zacks
X2 months Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.2% – Time to Sell? MarketBeat
X2 months Johnson & Johnson (NYSE:JNJ) Sees Significant Drop in Short Interest MarketBeat
X2 months The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction Zacks
X2 months Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific Zacks
X2 months Johnson & Johnson (NYSE:JNJ) Stock Price Up 0.2% – Still a Buy? MarketBeat
X2 months J&J Snack Foods (NASDAQ:JJSF) Earns Buy Rating from Benchmark MarketBeat
X2 months Johnson & Johnson (NYSE:JNJ) Shares Sold by State of Alaska Department of Revenue MarketBeat
X2 months Johnson & Johnson (NYSE:JNJ) Trading Up 0.5% – What’s Next? MarketBeat
X2 months Allworth Financial LP Boosts Position in Johnson & Johnson (NYSE:JNJ) MarketBeat
X2 months Commonwealth Financial Services LLC Has $584,000 Stake in Johnson & Johnson (NYSE:JNJ) MarketBeat
X2 months Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.7% – Here’s What Happened MarketBeat
X2 months Johnson & Johnson (NYSE:JNJ) Shares Acquired by Sequoia Financial Advisors LLC MarketBeat
X2 months Johnson & Johnson (NYSE:JNJ) Trading Down 0.1% – Here’s Why MarketBeat
X2 months Border to Coast Pensions Partnership Ltd Raises Position in Johnson & Johnson (NYSE:JNJ) MarketBeat
X2 months The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi Zacks
X2 months Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.8% – Here’s Why MarketBeat
X2 months Kenvue shares surge after activist Starboard takes stake CNBC
X2 months Johnson & Johnson (NYSE:JNJ) Shares Sold by Claro Advisors LLC MarketBeat
X2 months Starboard Value takes stake in JNJ spin-off Kenvue- WSJ Investing.com
X2 months Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue The Wall Street Journal
X2 months Allspring Global Investments Holdings LLC Raises Stake in J&J Snack Foods Corp. (NASDAQ:JJSF) MarketBeat
X2 months Johnson & Johnson: Q3 Earnings Highlights Resilience And New Growth Seeking Alpha
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.